Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970 |
Resumo: | Introduction: The epidemiological and social relevance of dementia and mild cognitive impairment increases with life expectancy and prevalence of metabolic disorders. The recognition of an important role for dietary nutrients on cognitive functioning opens new preventive strategies. This work analyses the association between erythrocyte omega-3 index and omega-6 / omega-3 ratio and cognitive performance/ mild cognitive impairment.Material and Methods: We selected a random sample of individuals registered at a health centre aged ≥ 55 years. Participants were asked about their alimentary habits, erythrocyte indexes were determined and neuropsychological evaluation included the Montreal Cognitive Assessment and a comprehensive test battery.Results: Mean age of 90 participants was 64 years (sd = 5.6), 71.1% had four years of education and 40% of them had more than one vascular risk factor. Limits for omega-3 index and omega-6 / omega-3 ratio were 2.90 - 9.79 (mean = 6.20; sd = 1.50) and 1.14 - 2.95 (mean = 2.12; sd = 0.39), respectively. Montreal Cognitive Assessment scores ranged from 10 to 29 (mean = 22; sd = 4.5), increasing on average 1 - 2 points for above average omega-3 values and an omega-6 / omega-3 ratio ≤ 2 (Group 1) and decreasing 5 - 6 points for omega-3 below mean values and the same omega-6 / omega-3 ratio (Group 2). Prevalence of mild cognitive impairment was 25.6% (95% CI: 16.4 - 34.7), ranging from 12.5% to 83.3% in the two groups above.Discussion: This preliminary study is one of the first analyzing the repercussion of omega-3 index and omega-6 / omega-3 ratio on cognitive functioning, considering additionally the participant clinical and dietary profiles.Conclusion: The association found suggests that omega-3 and omega-6 / omega-3 ratio could be important biomarkers in the prevention of cognitive impairment. |
id |
RCAP_42fb9c2cc0c603496ed1f1d73ec7fc78 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/7970 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive ImpairmentRelevância dos Índices Ómega-3 e Razão Ómega-6 / Ómega-3 na Prevenção do Défice CognitivoAgingCognition DisordersFatty AcidsOmega-3Omega-6Ácidos Gordos Ómega-3Ácidos Gordos Ómega-6EnvelhecimentoPerturbações da CogniçãoIntroduction: The epidemiological and social relevance of dementia and mild cognitive impairment increases with life expectancy and prevalence of metabolic disorders. The recognition of an important role for dietary nutrients on cognitive functioning opens new preventive strategies. This work analyses the association between erythrocyte omega-3 index and omega-6 / omega-3 ratio and cognitive performance/ mild cognitive impairment.Material and Methods: We selected a random sample of individuals registered at a health centre aged ≥ 55 years. Participants were asked about their alimentary habits, erythrocyte indexes were determined and neuropsychological evaluation included the Montreal Cognitive Assessment and a comprehensive test battery.Results: Mean age of 90 participants was 64 years (sd = 5.6), 71.1% had four years of education and 40% of them had more than one vascular risk factor. Limits for omega-3 index and omega-6 / omega-3 ratio were 2.90 - 9.79 (mean = 6.20; sd = 1.50) and 1.14 - 2.95 (mean = 2.12; sd = 0.39), respectively. Montreal Cognitive Assessment scores ranged from 10 to 29 (mean = 22; sd = 4.5), increasing on average 1 - 2 points for above average omega-3 values and an omega-6 / omega-3 ratio ≤ 2 (Group 1) and decreasing 5 - 6 points for omega-3 below mean values and the same omega-6 / omega-3 ratio (Group 2). Prevalence of mild cognitive impairment was 25.6% (95% CI: 16.4 - 34.7), ranging from 12.5% to 83.3% in the two groups above.Discussion: This preliminary study is one of the first analyzing the repercussion of omega-3 index and omega-6 / omega-3 ratio on cognitive functioning, considering additionally the participant clinical and dietary profiles.Conclusion: The association found suggests that omega-3 and omega-6 / omega-3 ratio could be important biomarkers in the prevention of cognitive impairment.Introdução: A relevância epidemiológica e social da demência e do défice cognitivo ligeiro aumenta com a esperança de vida e prevalência das doenças metabólicas. O reconhecimento da importância dos nutrientes no funcionamento cognitivo perspectiva novas estratégias preventivas. Neste trabalho analisamos a associação entre os valores do índice ómega-3 e da razão ómega-6 / ómega-3 e desempenho cognitivo/ défice cognitivo ligeiro.Material e Métodos: Selecionamos uma amostra aleatória de utentes de um centro de saúde com idade ≥ 55 anos, que foram inquiridos sobre hábitos alimentares e sujeitos a avaliação neuropsicológica, incluindo o Montreal Cognitive Assessment, e determinando-se os índices indicados.Resultados: Os 90 participantes tinham em média 64 anos (dp = 5,6), 71,1% quatro anos de escolaridade e 40% mais de um factor de risco vascular. Os limites dos valores de ómega-3 e da razão ómega-6 / ómega-3 foram respectivamente 2,90 - 9,79 (média = 6,20; dp = 1,50) e 1,14 - 2,95 (média = 2,12; dp = 0,39). A pontuação no Montreal Cognitive Assessment variou entre 10 - 29 (média = 22,0; dp = 4,5), aumentando em média 1 - 2 pontos para valores de ómega-3 acima da média e uma razão ómega-6 / ómega-3 ≤ 2 (Grupo 1) e diminuindo 5 - 6 pontos para um valor de ómega-3 abaixo da média e a mesma razão ómega-6 / ómega-3 (Grupo 2). A prevalência de défice cognitivo ligeiro foi 25,6% (IC 95%:16,4 - 34,7%), variando entre 12,5% e 83,3% nos dois grupos mencionados.Discussão: Este estudo preliminar é um dos primeiros a analisar a repercussão do índice ómega-3 e da razão ómega-6 / ómega-3 na função cognitiva, considerando adicionalmente o perfil clínico e consumo alimentar dos participantes.Conclusão: A associação encontrada sugere que o índice ómega-3 e a razão ómega-6 / ómega-3 podem ser biomarcadores importantes na prevenção da deterioração cognitiva.Ordem dos Médicos2017-03-31info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970oai:ojs.www.actamedicaportuguesa.com:article/7970Acta Médica Portuguesa; Vol. 30 No. 3 (2017): March; 213-223Acta Médica Portuguesa; Vol. 30 N.º 3 (2017): Março; 213-2231646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/4971https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/5138https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/8965Direitos de Autor (c) 2017 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessNunes, BelinaPinho, CristinaSousa, CláudiaMelo, Alan RochaBandarra, NarcisaSilva, Maria Carolina2022-12-20T11:05:22Zoai:ojs.www.actamedicaportuguesa.com:article/7970Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:31.508353Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment Relevância dos Índices Ómega-3 e Razão Ómega-6 / Ómega-3 na Prevenção do Défice Cognitivo |
title |
Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment |
spellingShingle |
Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment Nunes, Belina Aging Cognition Disorders Fatty Acids Omega-3 Omega-6 Ácidos Gordos Ómega-3 Ácidos Gordos Ómega-6 Envelhecimento Perturbações da Cognição |
title_short |
Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment |
title_full |
Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment |
title_fullStr |
Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment |
title_full_unstemmed |
Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment |
title_sort |
Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment |
author |
Nunes, Belina |
author_facet |
Nunes, Belina Pinho, Cristina Sousa, Cláudia Melo, Alan Rocha Bandarra, Narcisa Silva, Maria Carolina |
author_role |
author |
author2 |
Pinho, Cristina Sousa, Cláudia Melo, Alan Rocha Bandarra, Narcisa Silva, Maria Carolina |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Nunes, Belina Pinho, Cristina Sousa, Cláudia Melo, Alan Rocha Bandarra, Narcisa Silva, Maria Carolina |
dc.subject.por.fl_str_mv |
Aging Cognition Disorders Fatty Acids Omega-3 Omega-6 Ácidos Gordos Ómega-3 Ácidos Gordos Ómega-6 Envelhecimento Perturbações da Cognição |
topic |
Aging Cognition Disorders Fatty Acids Omega-3 Omega-6 Ácidos Gordos Ómega-3 Ácidos Gordos Ómega-6 Envelhecimento Perturbações da Cognição |
description |
Introduction: The epidemiological and social relevance of dementia and mild cognitive impairment increases with life expectancy and prevalence of metabolic disorders. The recognition of an important role for dietary nutrients on cognitive functioning opens new preventive strategies. This work analyses the association between erythrocyte omega-3 index and omega-6 / omega-3 ratio and cognitive performance/ mild cognitive impairment.Material and Methods: We selected a random sample of individuals registered at a health centre aged ≥ 55 years. Participants were asked about their alimentary habits, erythrocyte indexes were determined and neuropsychological evaluation included the Montreal Cognitive Assessment and a comprehensive test battery.Results: Mean age of 90 participants was 64 years (sd = 5.6), 71.1% had four years of education and 40% of them had more than one vascular risk factor. Limits for omega-3 index and omega-6 / omega-3 ratio were 2.90 - 9.79 (mean = 6.20; sd = 1.50) and 1.14 - 2.95 (mean = 2.12; sd = 0.39), respectively. Montreal Cognitive Assessment scores ranged from 10 to 29 (mean = 22; sd = 4.5), increasing on average 1 - 2 points for above average omega-3 values and an omega-6 / omega-3 ratio ≤ 2 (Group 1) and decreasing 5 - 6 points for omega-3 below mean values and the same omega-6 / omega-3 ratio (Group 2). Prevalence of mild cognitive impairment was 25.6% (95% CI: 16.4 - 34.7), ranging from 12.5% to 83.3% in the two groups above.Discussion: This preliminary study is one of the first analyzing the repercussion of omega-3 index and omega-6 / omega-3 ratio on cognitive functioning, considering additionally the participant clinical and dietary profiles.Conclusion: The association found suggests that omega-3 and omega-6 / omega-3 ratio could be important biomarkers in the prevention of cognitive impairment. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-03-31 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970 oai:ojs.www.actamedicaportuguesa.com:article/7970 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/7970 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/4971 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/5138 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7970/8965 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2017 Acta Médica Portuguesa info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2017 Acta Médica Portuguesa |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 30 No. 3 (2017): March; 213-223 Acta Médica Portuguesa; Vol. 30 N.º 3 (2017): Março; 213-223 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1817550844125511680 |